Form 4: Aveanna Healthcare Holdings Director Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Paul R. Vigano, a director of Aveanna Healthcare Holdings, reported the sale of common stock held indirectly through various entities, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Paul R. Vigano, a director of Aveanna Healthcare Holdings, reported the sale of common stock on May 14 and 15, 2025.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 13, 2024, by J.H. Whitney VII, L.P. and other Stockholder Entities.
- On May 14, 2025, shares were sold at a weighted average price of $5.88, with prices ranging from $5.84 to $5.94.
- On May 15, 2025, shares were sold at a weighted average price of $5.89, with prices ranging from $5.84 to $5.96.
- The sales were conducted by various entities including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, and JHW Iliad Holdings II LLC.
- Vigano disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing simply reports stock sales under a pre-existing 10b5-1 plan, with no indication of positive or negative implications for the company's performance.
Risks
- The sales by a director, even under a 10b5-1 plan, could be perceived negatively by investors.
Future Outlook
The filing indicates ongoing sales under a pre-arranged trading plan, suggesting continued transactions may occur.
Industry Context
Sales by directors are common and often pre-planned to avoid accusations of insider trading. The use of a 10b5-1 plan provides a legal framework for these transactions.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders if they perceive it as a lack of confidence by the director, although the 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Date of adoption of Rule 10b5-1 trading plan by J.H. Whitney VII, L.P. and other Stockholder Entities |
| 2025-05-14 | Date of first reported transaction: sale of common stock at a weighted average price of $5.88 |
| 2025-05-15 | Date of second reported transaction: sale of common stock at a weighted average price of $5.89 |
| 2025-05-16 | Date of Form 4 filing |
Keywords
Aveanna Healthcare Holdings, AVAH, Paul R. Vigano, Form 4, Stock Sale, 10b5-1 Trading Plan, J.H. Whitney VII, PSA Healthcare Investment Holding LLC, JHW Iliad Holdings LLC, PSA Iliad Holdings LLC, JHW Iliad Holdings II LLC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.